Frequency of metabolic syndrome in obsessive compulsive disorder patients on antidepressant monotherapy vs antidepressant plus atypical antipsychotic combination therapy: a naturalistic, descriptive pilot study -

作者: Esen Savaş , Arzu Özovacı , Mehmet Hanifi Kokaçya , Abdurrahman Altındağ , Osman Vırıt

DOI: 10.1080/10177833.2010.11790677

关键词: Atypical antipsychoticAntidepressantPsychiatryGynecologyMedicineObsessive compulsiveCombination therapyMetabolic syndrome

摘要: OZETAmac: Obsesif kompulsif bozukluk (OKB) hastalarindaki metabolik sendrom (MetS) sikligini saptamak, MetS ile hastalarin sosyode-mografik ozellikleri ve kullandiklari ilaclarin; yani atipik antipsikotik eklenmis antidepresan kullanimiyla veya sadece arasindaki olasi iliskinin incelenmesi amaclanmistir.Yontem: Bu arastirmaya, Gaziantep Universitesi Tip Fakultesi Ruh Sagligi Hastaliklari Anabilim Dali Anksiyete Bozukluklari Birimi'ne ayaktan tedaviye devam eden, 18–65 yas arasi, DSM-IV TR olcutlerine gore arastirmadan once OKB tanisi almis, kullanmakta olan hastalar (antidepresan grubu) antidepresanla birlikte (antipsikotik halen oldugu ilaclari en az son uc aydir kullanmaya ediyor 20′ser hastasi olmak uzere toplam 40 hasta alinmistir. Calisma yontemi olarak “naturalistik, tanimlayici klinik gozlem” kullanilmistir. Kisinin sosyal islevselligini etkileyebilecek mental olmayan kronik tibbi...

参考文章(32)
Haluk A Savas, Mehmet Yumru, Murat E Özen, Quetiapine and ziprasidone as adjuncts in treatment-resistant obsessive-compulsive disorder: a retrospective comparative study. Clinical Drug Investigation. ,vol. 28, pp. 439- 442 ,(2008) , 10.2165/00044011-200828070-00005
S Santamarina Montila, MJ Alonso Villa, C Iglesias García, [Ziprasidone as coadjuvant treatment in resistant obsessive-compulsive disorder treatment]. Actas Espanolas De Psiquiatria. ,vol. 34, pp. 277- 279 ,(2006)
A. K. B. Van Reedt Dortland, E. J. Giltay, T. Van Veen, F. G. Zitman, B. W. J. H. Penninx, Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use. Acta Psychiatrica Scandinavica. ,vol. 122, pp. 30- 39 ,(2009) , 10.1111/J.1600-0447.2010.01565.X
Tuula Heiskanen, Leo Niskanen, Riitta Lyytikäinen, Pirjo I. Saarinen, Jukka Hintikka, Metabolic syndrome in patients with schizophrenia. The Journal of Clinical Psychiatry. ,vol. 64, pp. 575- 579 ,(2003) , 10.4088/JCP.V64N0513
G. M. Reaven, A. Laws, Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease. Diabetologia. ,vol. 37, pp. 948- 952 ,(1994) , 10.1007/BF00400953
B Millet, F Kochman, T Gallarda, M.O Krebs, F Demonfaucon, I Barrot, M.C Bourdel, J.P Olié, H Loo, E.G Hantouche, Phenomenological and comorbid features associated in obsessive–compulsive disorder: influence of age of onset Journal of Affective Disorders. ,vol. 79, pp. 241- 246 ,(2004) , 10.1016/S0165-0327(02)00351-8
T. Baptista, N. M. Kin, S. Beaulieu, E. A. de Baptista, Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives. Pharmacopsychiatry. ,vol. 35, pp. 205- 219 ,(2002) , 10.1055/S-2002-36391
Altan Onat, Hakan Özhan, A. Metin Esen, Sinan Albayrak, Ahmet Karabulut, Günay Can, Gülay Hergenç, Prospective epidemiologic evidence of a “protective” effect of smoking on metabolic syndrome and diabetes among Turkish women—Without associated overall health benefit Atherosclerosis. ,vol. 193, pp. 380- 388 ,(2007) , 10.1016/J.ATHEROSCLEROSIS.2006.07.002
Damiaan Denys, Femke de Geus, Harold J. G. M. van Megen, Herman G. M. Westenberg, A Double-Blind, Randomized, Placebo-Controlled Trial of Quetiapine Addition in Patients With Obsessive-Compulsive Disorder Refractory to Serotonin Reuptake Inhibitors The Journal of Clinical Psychiatry. ,vol. 65, pp. 1040- 1048 ,(2004) , 10.4088/JCP.V65N0803